Major adverse cardiovascular events and the timing and dose of corticosteroids in immune checkpoint inhibitor-associated myocarditis Research Letter

   

Authors:	Zhang, L.; Zlotoff, D. A.; Awadalla, M.; Mahmood, S. S.; Nohria, A.; Hassan, M. Z. O.; Thuny, F.; Zubiri, L.; Chen, C. L.; Sullivan, R. J.; Alvi, R. M.; Rokicki, A.; Murphy, S. P.; Jones-O'Connor, M.; Heinzerling, L. M.; Barac, A.; Forrestal, B. J.; Yang, E. H.; Gupta, D.; Kirchberger, M. C.; Shah, S. P.; Rizvi, M. A.; Sahni, G.; Mandawat, A.; Mahmoudi, M.; Ganatra, S.; Ederhy, S.; Zatarain-Nicolas, E.; Groarke, J. D.; Tocchetti, C. G.; Lyon, A. R.; Thavendiranathan, P.; Cohen, J. V.; Reynolds, K. L.; Fradley, M. G.; Neilan, T. G.
Title:	Major adverse cardiovascular events and the timing and dose of corticosteroids in immune checkpoint inhibitor-associated myocarditis
Keywords:	immunotherapy; corticosteroid; myocarditis
Journal Title:	Circulation
Volume:	141
Issue:	24
ISSN:	0009-7322
Publisher:	Lippincott Williams & Wilkins
Date Published:	2020-06-16
Start Page:	2031
End Page:	2034
Language:	English
DOI:	10.1161/circulationaha.119.044703
PUBMED:	32539614
PROVIDER:	scopus
PMCID:	PMC7301778
DOI/URL:	https://www.scopus.com/inward/record.uri?eid=2-s2.0-85086624774&doi=10.1161%2fCIRCULATIONAHA.119.044703&partnerID=40&md5=cca022d1cd81a07a48f46c615a6d8768
Notes:	Letter -- Export Date: 1 July 2020 -- Source: Scopus

https://synapse.mskcc.org/synapse/works/has_related_data_chk/167298